Research Article
High Body Mass Index and Triglycerides Help Protect against Osteoporosis in Patients with Type 2 Diabetes Mellitus
Table 1
Clinical characteristics of patients with T2DM by BMI category.
| | Normal weight group (20–24.9 kg/m2) | Overweight/obese group (≥25 kg/m2) | value |
| | 29 | 50 | | Sex (F, %) | 25 (51.7%) | 20 (40%) | 0.312 | Age (years) | | | 0.019 | DM course (years) | | | | 0-1 | 7 (24.1%) | 13 (26.0%) | | 1-10 | 14 (48.3%) | 21 (42.0%) | 0.858 | >10 | 8 (27.6%) | 16 (32.0%) | | History of DM | 10 (34.5%) | 16 (32.0%) | 0.821 | Hypertension | 11 (37.9%) | 25 (50.0%) | 0.299 | Gastrointestinal disorders | 4 (13.8%) | 6 (12.0%) | 1.000 | Smoking | 7 (24.1%) | 19 (38.0%) | 0.206 | Drinking | 6 (20.7%) | 19 (38.0%) | 0.111 | HbA1c (%) | 9.6 (4.2) | 9.0 (2.4) | 0.376 | TC (mmol/L) | | | 0.268 | TG (mmol/L) | 1.41 (1.01) | 1.59 (1.18) | 0.095 | HDL-C (mmol/L) | | | 0.031 | LDL-C (mmol/L) | | | 0.303 | VLDL-C (mmol/L) | 0.46 (0.22) | 0.47 (0.38) | 0.508 | ApoA1 (mmol/L) | | | 0.294 | ApoB (mmol/L) | | | 0.831 | Total protein (g/L) | | | 0.743 | Albumin (g/L) | | | 0.749 | BUN (mmol/L) | | | 0.442 | Cr (μmmol/L) | | | 0.180 | 25OHD (ng/mL) | 13.18 (9.81) | 15.25 (9.92) | 0.248 | OC (ng/mL) | | | 0.421 | β-CTX (ng/mL) | 0.40 (0.29) | 0.38 (0.33) | 0.827 | P1NP (ng/mL) | 38.77 (17.46) | 42.76 (29.99) | 0.935 | PTH (pg/mL) | | | 0.915 | OP | 20 (69.0%) | 15 (30.0%) | 0.001 |
|
|
Note: data were expressed as number (%) or (interquartile range). Abbreviations: ApoA1: apolipoprotein A1; ApoB: apolipoprotein B; BMD: bone mineral density; BMI: body mass index; BUN: blood urea nitrogen; Cr: creatinine; DM: diabetes mellitus; HbA1c: glycated hemoglobin; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; T2DM: type 2 diabetes mellitus; TC: total cholesterol; TG: triglyceride; VLDL-C: very-low-density lipoprotein cholesterol; OC: osteocalcin; OP: osteoporosis; P1NP: procollagen type 1 N-terminal propeptide; PTH: parathyroid hormone; 25OHD: 25-hydroxyvitamin D; β-CTX: β-C-terminal cross-linked telopeptide of type I collagen. |